Company intelligence / Profile preview

Nanjing Aidecheng Pharmaceutical Technology

Nanjing, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Nanjing Aidecheng Pharmaceutical Technology is a clinical-stage biotechnology company based in Nanjing, China, dedicated to the development of innovative small molecule drugs for oncology. The company's lead candidate, ADC-189, is a highly selective PARP inhibitor designed to treat various solid tumors, including ovarian and breast cancers. Aidecheng leverages its internal research and development platform to identify and optimize novel chemical entities with improved safety and efficacy profiles. Supported by prominent venture capital firms like HighLight Capital, the company is advancing its pipeline through clinical trials in China. Aidecheng focuses on precision medicine to provide effective therapeutic options for patients with unmet medical needs. The company is headquartered in the Nanjing Jiangbei New Area, a significant hub for life sciences and pharmaceutical innovation.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Nanjing Aidecheng Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanjing Aidecheng Pharmaceutical Technology.

Explore the full profile